GlassScriptPhysician profile
Amanda S Dye
NPI 1568626828
$2,829.27
in general payments reported to CMS, 2019-2025
18 companies · $471 in 2025
The $471 reported for 2025 was more than what a typical Pediatric Endocrinology provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $55.12 · 2021: $11.04 · 2022: $95.28 · 2023: $468 · 2024: $1,729 · 2025: $471.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,465 · Food and Beverage: $1,139 · Education: $64.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,464.56 |
| Food and Beverage | $1,138.73 |
| Education | $64.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,074.50 | 2023-2025 | Minimed 780g |
| Novo Nordisk INC | $118.66 | 2019-2025 | Sogroya, Wegovy |
| Insulet Corporation | $102.27 | 2019-2025 | Omnipod |
| Abbott Laboratories | $99.32 | 2021-2025 | Freestyle Libre 3 |
| Tandem Diabetes Care, INC. | $72.38 | 2023-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Abbvie INC. | $51.70 | 2019-2024 | |
| Tolmar Pharmaceuticals, INC. | $42.00 | 2022 | |
| Azurity Pharmaceuticals, INC. | $38.65 | 2024-2025 | Triptodur |
| Alexion Pharmaceuticals, INC. | $36.91 | 2024 | Strensiq |
| Soleno Therapeutics, INC. | $29.57 | 2025 | Vykat Xr |
| Pfizer INC. | $28.57 | 2025 | |
| Kyowa Kirin, INC. | $23.92 | 2025 | |
| Sandoz INC. | $23.62 | 2025 | Omnitrope |
| Rhythm Pharmaceuticals, INC. | $21.87 | 2023 | Imcivree |
| Dexcom, INC. | $20.42 | 2025 | Dexcom G6 Transmitter |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $19.51 | 2025 | |
| Sequel Med Tech, LLC | $13.63 | 2025 | Twiist |
| Therapeuticsmd, INC. | $11.77 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Dye listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.